SCHEMBL28366388

SCHEMBL28366388

O=c1c2cc([N+](=O)[O-])ccc2ccn1-c1cccc(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 2/20 0.45
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
KIF11 P52732 2/20 0.43
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TNFSF11 O14788 1/20 0.42
G6PD P11413 1/20 0.42
TLR9 Q9NR96 1/20 0.42
ABCG2 Q9UNQ0 5/20 0.41
HTT P42858 1/20 0.41
SLC6A9 P48067 1/20 0.41
SLC6A5 Q9Y345 1/20 0.41
ABL1 P00519 1/20 0.40
LCK P06239 1/20 0.40
KIT P10721 1/20 0.40
SRC P12931 1/20 0.40
PDGFRA P16234 1/20 0.40
PHOSPHO1 Q8TCT1 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28366232 0.88 KIF11 (0.45) KIF11SMN1; SMN2G6PDTLR9SLC6A9
SCHEMBL28057350 0.83 ALDH1A1 (0.49) KEAP1NFE2L2LMNASMN1; SMN2G6PD
SCHEMBL23902692 0.82 LMNA (0.49) TNFKEAP1NFE2L2KIF11LMNA
SCHEMBL30241541 0.82 LMNA (0.49) TNFKEAP1NFE2L2KIF11LMNA
SCHEMBL14966484 0.80 KEAP1 (0.46) KEAP1NFE2L2KIF11LMNASMN1; SMN2
Trifluoromethanesulfonic Acid SCHEMBL27781891 0.72 POLB (0.38) LMNASMN1; SMN2PHOSPHO1MAPT
SCHEMBL9920084 0.72 MEN1 (0.55) HTTMAPTRXFP1
SCHEMBL807891 0.71 G6PD (0.43) KIF11LMNAG6PDTLR9ABL1
SCHEMBL439710 0.70 TSHR (0.61) KEAP1NFE2L2KIF11LMNAMAPT
SCHEMBL29703748 0.70 TSHR (0.61) KEAP1NFE2L2KIF11LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105523996-B Amide derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2020-03-06 CN disclosed